BioLife Solutions Executes Supply Agreement with Adaptimmune for CryoStor® Use in SPEAR T-Cell Platform
Proprietary Clinical Grade Cell Freeze Media Enables Long-Term Storage and Distribution of T-Cells BOTHELL, Wash., June 14, 2017 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers (“BioLife” or the “Company”), today announced that it has... Read more